Tripartite motif 38 alleviates the pathological process of NAFLD–NASH by promoting TAB2 degradation
Nonalcoholic fatty liver disease (NAFLD) has become the most prevalent chronic liver disease worldwide, without any Food and Drug Administration-approved pharmacological intervention in clinic. Trim38, as an important member of the TRIM (tripartite motif-containing) family, was largely reported to b...
Main Authors: | Xinxin Yao, Ruixiang Dong, Sha Hu, Zhen Liu, Jie Cui, Fengjiao Hu, Xu Cheng, Xiaoming Wang, Tengfei Ma, Song Tian, Xiao-Jing Zhang, Yufeng Hu, Lan Bai, Hongliang Li, Peng Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-07-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S002222752300055X |
Similar Items
-
Trim Tab Flight Stabilisation System Performance Assessment under Degraded Actuator Speeds
by: Albert Zajdel, et al.
Published: (2023-04-01) -
Magnesium lithospermate B protects cardiomyocytes from ischemic injury via inhibition of TAB1-p38 apoptosis signaling
by: Chang-Sheng Du, et al.
Published: (2010-08-01) -
Usefulness of the SAF score to characterize NAFLD/NASH in non-cirrhotic HCV patients
by: Ahmed El Ray, et al.
Published: (2022-08-01) -
Nicotinamide and NAFLD: Is There Nothing New Under the Sun?
by: Maria Guarino, et al.
Published: (2019-09-01) -
Tab Design and Failures in Cylindrical Li-ion Batteries
by: Xing-Yan Yao, et al.
Published: (2019-01-01)